Omeros Corp. (OMER)
9.85
+0.06
(+0.61%)
USD |
NASDAQ |
Jun 08, 16:00
9.85
0.00 (0.00%)
After-Hours: 16:40
Omeros EPS Diluted (Quarterly) : 0.7795 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novo Nordisk A/S | 1.709 |
| Phibro Animal Health Corp. | 0.5854 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 51.25M |
| Revenue (Quarterly) | 9.893M |
| Total Expenses (Quarterly) | -41.36M |
| Enterprise Value | 880.18M |
| Gross Profit Margin (Quarterly) | 91.65% |
| Earnings Yield | 8.69% |
| Normalized Earnings Yield | 11.33 |